We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+19.44%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$2.38B
AUM Growth
-$27.3M
Cap. Flow
-$219M
Cap. Flow %
-9.21%
Top 10 Hldgs %
39.28%
Holding
114
New
41
Increased
19
Reduced
15
Closed
25

Top Buys

Rank Stock Value
1
BHVN icon
Biohaven
BHVN
+$53.5M
2
T icon
AT&T
T
+$52.8M
3
NKE icon
Nike
NKE
+$50.1M
4
WYNN icon
Wynn Resorts
WYNN
+$50.1M
5
FIS icon
Fidelity National Information Services
FIS
+$49.2M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$89.1M
2
DIS icon
Walt Disney
DIS
+$87.4M
3
AMZN icon
Amazon
AMZN
+$82.9M
4
IQV icon
IQVIA
IQV
+$71.9M
5
GPN icon
Global Payments
GPN
+$71.2M

Sector Composition

Rank Sector Weight
1 Healthcare 46.26%
2 Consumer Discretionary 16.29%
3 Industrials 12.13%
4 Consumer Staples 8.08%
5 Technology 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
76
Intuitive Surgical
ISRG
$134B
$411K 0.02%
+1,550
New +$378K
SYK icon
77
Stryker
SYK
$130B
$406K 0.02%
+1,660
New +$377K
BIIB icon
78
Biogen
BIIB
$30.7B
$396K 0.02%
+1,430
New +$404K
IDXX icon
79
Idexx Laboratories
IDXX
$46.2B
$375K 0.02%
+920
New +$357K
WAT icon
80
Waters Corp
WAT
$39.9B
$325K 0.01%
+950
New +$301K
BMRN icon
81
BioMarin Pharmaceuticals
BMRN
$12.4B
$276K 0.01%
+2,670
New +$251K
CVS icon
82
CVS Health
CVS
$122B
$267K 0.01%
+2,870
New +$277K
MTD icon
83
Mettler-Toledo International
MTD
$28.6B
$237K 0.01%
+164
New +$220K
BMY icon
84
Bristol-Myers Squibb
BMY
$132B
$236K 0.01%
+3,280
New +$247K
GMAB icon
85
Genmab
GMAB
$19.5B
$221K 0.01%
+5,210
New +$215K
CRL icon
86
Charles River Laboratories
CRL
$12.8B
$220K 0.01%
+1,010
New +$221K
TECH icon
87
Bio-Techne
TECH
$11.3B
$215K 0.01%
+2,600
New +$206K
BNTC icon
88
Benitec Biopharma
BNTC
$468M
$131K 0.01%
45,235
OHAAW
89
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
$3.65K ﹤0.01%
72,605
AMZN icon
90
Amazon
AMZN
$2.96T
-733,460
Closed -$82.9M
BOLT icon
91
Bolt Biotherapeutics
BOLT
$7.78M
-133,600
Closed -$3.96M
DIS icon
92
Walt Disney
DIS
$181B
-926,850
Closed -$87.4M
GPN icon
93
Global Payments
GPN
$22.8B
-658,992
Closed -$71.2M
HRTX icon
94
Heron Therapeutics
HRTX
$92.9M
-2,807,000
Closed -$11.8M
IRON icon
95
Disc Medicine
IRON
$2.97B
-79,076
Closed -$3.89M
LEGN icon
96
Legend Biotech
LEGN
$4.01B
-274,200
Closed -$11.2M
LLY icon
97
Eli Lilly
LLY
$1.06T
-35,200
Closed -$11.4M
LVS icon
98
CALL
Las Vegas Sands
LVS
$29.6B
-890,000
Closed -$33.4M
MA icon
99
Mastercard
MA
$493B
-181,691
Closed -$51.7M
MAR icon
100
Marriott International
MAR
$92.3B
-134,800
Closed -$18.9M

Similar funds

Suvretta Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Suvretta Capital Management held 114 positions worth $2.38B, down 1.1% from $2.41B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Suvretta Capital Management withdrew a net $219M in Q4 2022, closing 25 positions and reducing 15 holdings. Its most notable exit was Microsoft, an estimated $89.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 45% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Suvretta Capital Management opened a new position in AT&T worth $54.3M.

  • Suvretta Capital Management's largest Q4 2022 buy was AT&T: 2,951,900 shares worth $54.3M.
  • Suvretta Capital Management added most to Biohaven in Q4 2022, an estimated $53.5M increase.
  • Suvretta Capital Management's biggest Q4 2022 reduction was IQVIA, cutting an estimated $71.9M.
  • Suvretta Capital Management fully exited Microsoft in Q4 2022, selling an estimated $89.1M.
  • Suvretta Capital Management's ten largest holdings make up 39% of its $2.38B portfolio in Q4 2022.
  • Suvretta Capital Management opened 41 new positions and closed 25 in Q4 2022.
  • Suvretta Capital Management's portfolio value fell 1.1% quarter-over-quarter to $2.38B.

Based on Suvretta Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.